Albany, NY -- (SBWIRE) -- 02/20/2015 -- There are no pharmacological treatments that are indicated for celiac disease and the current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases, targeting approximately 5% of the celiac disease patient population and there are no preventative medications. The anticipated launch of Alba/Teva's larazotide acetate in 2018 in the US and 2019 in 5EU, followed by the launch of Alvine/AbbVie's latiglutenase in 2019 and 2020 in the US and 5EU respectively are set to change the management of the disease and drive growth in the celiac disease market. Both drugs are expected to target patients who undergo gluten exposure while on a GFD equating to approximately 95% of the celiac disease patient population. GlobalData estimates that the uptake of both drugs will be equally high, but latiglutenase will rapidly gain market value and emerge the commercially stronger drug with the backing of Immune-Gastro veteran AbbVie.

Browse Detail Report With TOC
http://www.researchmoz.us/opportunityanalyzer-celiac-disease-opportunity-analysis-and-forecast-to-2023-report.html

Highlights

Key Questions Answered

(Q.) How will the celiac disease market landscape change within the 2013-2018 and the 2013-2023 forecast periods in the 6MM?

(Q.) What are the most promising late-stage pipeline drugs and how will their launch shape the future treatment landscape in the celiac disease market?

(Q.) How do the clinical and commercial attributes of late-stage pipeline drugs compare to one another and against existing treatment options?

(Q.) What are the significant unmet needs in the celiac disease market?

(Q.) What are the remaining opportunities in the celiac disease market?

Request for Sample Report
http://www.researchmoz.com/enquiry.php?type=sample&repid=244452

Key Findings

High uptake is expected of pipeline drugs for celiac disease that are anticipated to launch during the 2013-2023 forecast period.

Celiac disease remains a field of highly unattained unmet need.

There is no consensus over clinical trial design and endpoints for the development of celiac disease products.

The clinical stage pipeline is mainly focussed on GFD adjunctive therapies, while the pre-clinical stage pipeline has shifted its focus to disease modifying treatments.

Significant opportunity exists for products targeting in the non-refractory patient segment of the celiac disease market.

M&A's and alliance opportunities will be key factors in driving celiac disease drug development.

Browse All Reports in Pharmaceutical Category
http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Scope

Overview of celiac disease, including epidemiology, etiology, pathophysiology, symptoms and current treatment options

Annualized celiac disease therapeutics market revenue, annual cost of therapies and forecasts for five years to 2018 and ten years to 2023.

Key topics covered include strategic product assessment, market characterization, unmet needs, R&D strategies, clinical trial design and implications for the celiac disease therapeutics market.

Pipeline analysis: comprehensive data split across different phases, emerging trends and mechanisms of action under development, including zonulin inhibitors, gluten peptide enzymes, gluten specific synthetic polymers and therapeutic vaccines.

Analysis of the current and future market competition in the US and five major EU celiac disease therapeutics market. Clinical and commercial benchmarking of promising pipeline products versus standard of care treatments and competitive assessment of all therapies. Insightful review of the key industry drivers, restraints and challenges.

For Market Research Latest Reports Visit
http://www.researchmoz.us/latest-report.html

Reasons to buy

The report will enable you to

Identify the unmet needs and remaining opportunities in the celiac disease therapeutics market.

Develop business strategies by understanding the trends shaping and driving the US and five major EU celiac disease therapeutics market.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Assess the clinical and commercial viability of promising pipeline products.

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various emerging therapies.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Drive revenues by understanding the key trends, innovative products and technologies, market and segments likely to impact the US and five major EU celiac disease therapeutics market in future.

Related Reports

Global Preventable Vaccines Market 2015-2019

(http://www.researchmoz.us/global-preventable-vaccines-market-2015-2019-report.html)

About Preventable Vaccines Vaccines can be defined as a product that stimulates a persons immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and...

Global Infertility Market 2015-2019

(http://www.researchmoz.us/global-infertility-market-2015-2019-report.html)

About Infertility Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors...

For More Reports Browse
https://www.linkedin.com/today/author/68229468

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Email: sales@researchmoz.us